Andrijauskaite K, Suriano S, Cloud C A, Li M, Kesarwani P, Stefanik L S, Moxley K M, Salem M L, Garrett-Mayer E, Paulos C M, Mehrotra S, Kochenderfer J N, Cole D J, Rubinstein M P
Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Cancer Gene Ther. 2015 Jul;22(7):360-7. doi: 10.1038/cgt.2015.28. Epub 2015 Jul 17.
The ability to genetically modify T cells is a critical component to many immunotherapeutic strategies and research studies. However, the success of these approaches is often limited by transduction efficiency. As retroviral vectors require cell division for integration, transduction efficiency is dependent on the appropriate activation and culture conditions for T cells. Naive CD8(+) T cells, which are quiescent, must be first activated to induce cell division to allow genetic modification. To optimize this process, we activated mouse T cells with a panel of different cytokines, including interleukin-2 (IL-2), IL-4, IL-6, IL-7, IL-12, IL-15 and IL-23, known to act on T cells. After activation, cytokines were removed, and activated T cells were retrovirally transduced. We found that IL-12 preconditioning of mouse T cells greatly enhanced transduction efficiency, while preserving function and expansion potential. We also observed a similar transduction-enhancing effect of IL-12 preconditioning on human T cells. These findings provide a simple method to improve the transduction efficiencies of CD8(+) T cells.
对T细胞进行基因改造的能力是许多免疫治疗策略和研究的关键组成部分。然而,这些方法的成功往往受到转导效率的限制。由于逆转录病毒载体需要细胞分裂才能整合,转导效率取决于T细胞合适的激活和培养条件。静止的初始CD8(+) T细胞必须首先被激活以诱导细胞分裂,从而实现基因改造。为了优化这一过程,我们用一组已知作用于T细胞的不同细胞因子激活小鼠T细胞,这些细胞因子包括白细胞介素-2(IL-2)、IL-4、IL-6、IL-7、IL-12、IL-15和IL-23。激活后,去除细胞因子,然后用逆转录病毒转导激活的T细胞。我们发现,对小鼠T细胞进行IL-12预处理可大大提高转导效率,同时保留其功能和扩增潜力。我们还观察到IL-12预处理对人T细胞有类似的转导增强作用。这些发现提供了一种提高CD8(+) T细胞转导效率的简单方法。